FDA.reportPublic FDA data

LIOTHYRONINE SODIUM

Product NDC
51655-122
11-digit product format
516550122
Labeler code
51655
Product ID
51655-122_05548cb8-6ee3-47a4-960e-6b2d576240aa
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LIOTHYRONINE SODIUM
Dosage form
TABLET
Route
ORAL
Labeler
Northwind Pharmaceuticals
Application
ANDA200295
Marketing category
ANDA
Marketing start
2014-12-29
Marketing end
0000-00-00
Substance
LIOTHYRONINE SODIUM
Active strength
50 ug/1
Pharmacologic classes
l-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51655-122-522026-01-07C16284748780-19d75b9d0-b254-f424-e053-dadaa90a57cee6c9e50b-d5e6-44b8-a601-82f7baf9b28e
51655-122-522020-01-31C16284748780-19d75b9d0-b254-f424-e053-dadaa90a57cee6c9e50b-d5e6-44b8-a601-82f7baf9b28e

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LIOTHYRONINE SODIUMACTIVE INGREDIENTGCA9VV7D2NLIOTHYRONINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS]1
LIOTHYRONINEACTIVE MOIETY06LU7C9H1VLIOTHYRONINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51655-122LIOTHYRONINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS]1Legacy NDC20150122_e6c9e50b-d5e6-44b8-a601-82f7baf9b28e.zip